|Mr. Stuart John Ashman||CEO & Executive Director||432.36k||無||1967|
|Mr. Manprit Singh Randhawa||CFO, Secretary & Director||304.64k||無||1984|
|Dr. Catherine O'Neill||Chief Scientific Officer & Member of Scientific Advisory Board||48.69k||無||無|
|Laura Bey||Head of Formulations||無||無||無|
|Ms. Melissa Greenwell||Group Financial Controller||無||無||無|
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
截至 無 止，SkinBioTherapeutics plc 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。